Please login to the form below

Not currently logged in
Email:
Password:

PPRS changes delayed

The Department of Health has postponed the date on which pharmaceutical companies will be required to reduce the price of its non-exclusive medicines

The Department of Health has postponed the date on which pharmaceutical companies will be required to reduce the price of its non-exclusive medicines.

The new Pharmaceutical Price Regulation Scheme (PPRS), a joint initiative from the Department of Health (DH) and the Association of the British Pharmaceutical Industry (ABPI), was due to take effect from January 1, 2009.

A key part of this new scheme is a requirement for pharmaceutical companies to reduce the price of their branded medicines once they are off-patent to bring them more inline with the price of generic equivalents. The DH has since decided that a public consultation is required, which will delay the launch of the scheme by at least three months.

This change is likely to cause uncertainty for pharmaceutical companies after they agreed a deal earlier this year to reduce prices of branded generic drugs to 1.5 times the reimbursement rate for generics. Any change to this rate will also have a negative impact on manufacturers of generic medicines.

23rd October 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

Ali Frederic Ben-Amor
Tackling a formidable foe
Ali Frederic Ben-Amor tells how Merck is taking the fight to multiple sclerosis...
Geoff
Cancer care – the power of new technologies
With patient numbers set to soar, how can we make a difference?...
image 1
Redefining communications excellence
How to be heard in today’s multichannel, multistakeholder, multimedia world...

Infographics